메뉴 건너뛰기




Volumn 62, Issue 2, 2006, Pages 256-258

Risk factors for the acquisition of vancomycin-resistant enterococci during a single-strain outbreak at a major Australian teaching hospital [13]

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; FLUCLOXACILLIN; MACROLIDE; METRONIDAZOLE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

EID: 30344455982     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2005.06.018     Document Type: Letter
Times cited : (9)

References (8)
  • 1
    • 2442483761 scopus 로고    scopus 로고
    • Eradication of a large outbreak of a single strain of vanB vancomycin-resistant Enterococcus faecium at a major Australian teaching hospital
    • K.J. Christiansen P.A. Tibbett W. Beresford et al. Eradication of a large outbreak of a single strain of vanB vancomycin-resistant Enterococcus faecium at a major Australian teaching hospital Infect Control Hosp Epidemiol 25 2004 384-390
    • (2004) Infect Control Hosp Epidemiol , vol.25 , pp. 384-390
    • Christiansen, K.J.1    Tibbett, P.A.2    Beresford, W.3
  • 2
    • 30344449979 scopus 로고    scopus 로고
    • Screening and electronic labelling of ward contacts of vancomycin-resistant Enterococcus faecium vanB carriers during a single-strain hospital outbreak and after discharge from hospital
    • J.W. Pearman P.L. Perry F.P. Kosaras et al. Screening and electronic labelling of ward contacts of vancomycin-resistant Enterococcus faecium vanB carriers during a single-strain hospital outbreak and after discharge from hospital Commun Dis Intell 27 Suppl 2003 S97-S102
    • (2003) Commun Dis Intell , vol.27 , Issue.SUPPL.
    • Pearman, J.W.1    Perry, P.L.2    Kosaras, F.P.3
  • 3
    • 1542756460 scopus 로고    scopus 로고
    • Association between antecedent intravenous antimicrobial exposure and isolation of vancomycin-resistant enterococci
    • L.S. Chavers S.A. Moser E. Funkhouser et al. Association between antecedent intravenous antimicrobial exposure and isolation of vancomycin-resistant enterococci Microb Drug Resist 9 Suppl 1 2003 S69-S77
    • (2003) Microb Drug Resist , vol.9 , Issue.SUPPL. 1
    • Chavers, L.S.1    Moser, S.A.2    Funkhouser, E.3
  • 4
    • 0036093262 scopus 로고    scopus 로고
    • Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci
    • S. Harbarth S. Cosgrove Y. Carmeli Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci Antimicrob Agents Chemother 46 2002 1619-1628
    • (2002) Antimicrob Agents Chemother , vol.46 , pp. 1619-1628
    • Harbarth, S.1    Cosgrove, S.2    Carmeli, Y.3
  • 5
    • 0030055382 scopus 로고    scopus 로고
    • An audit of third generation cephalosporin prescribing in a tertiary care hospital
    • M. LeMire L. Wing D.L. Gordon An audit of third generation cephalosporin prescribing in a tertiary care hospital Aust N Z J Med 26 1996 386-390
    • (1996) Aust N Z J Med , vol.26 , pp. 386-390
    • LeMire, M.1    Wing, L.2    Gordon, D.L.3
  • 7
    • 0033543606 scopus 로고    scopus 로고
    • Prospective vancomycin audit in Auckland Healthcare hospitals
    • D. Drinkovic S.L. Taylor S. Pottumarthy et al. Prospective vancomycin audit in Auckland Healthcare hospitals N Z Med J 112 1999 336-339
    • (1999) N Z Med J , vol.112 , pp. 336-339
    • Drinkovic, D.1    Taylor, S.L.2    Pottumarthy, S.3
  • 8
    • 0037442625 scopus 로고    scopus 로고
    • Changes in the prevalence of vancomycin-resistant enterococci in response to antimicrobial formulary interventions: Impact of progressive restrictions on use of vancomycin and third-generation cephalosporins
    • E. Lautenbach L.A. LaRosa A.M. Marr et al. Changes in the prevalence of vancomycin-resistant enterococci in response to antimicrobial formulary interventions: Impact of progressive restrictions on use of vancomycin and third-generation cephalosporins Clin Infect Dis 36 2003 440-446
    • (2003) Clin Infect Dis , vol.36 , pp. 440-446
    • Lautenbach, E.1    LaRosa, L.A.2    Marr, A.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.